Advanced search
Publication Cover
International Journal of General Medicine Volume 15, 2022 - Issue
Submit an article Journal homepage
125
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Low Prevalence of Mild Alpha-1-Antitrypsin Deficiency in Hospitalized COVID-19-Patients

David Nygren1 Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, SwedenCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2426-7204View further author information
ORCID Icon,
Ulrica Mölstad2 Department of Research and Development, Health Care Region Kronoberg, Växjö, SwedenView further author information
,
Hans Thulesius2 Department of Research and Development, Health Care Region Kronoberg, Växjö, Sweden;3 Department of Medicine and Optometry, Linnaeus University, Växjö, Sweden;4 Department of Clinical Sciences, Family Medicine, Lund University, Malmö, SwedenORCID Iconhttps://orcid.org/0000-0002-3785-5630View further author information
ORCID Icon,
Magnus Hillman5 Diabetes Research Laboratory, Biomedical Center, Lund University, Lund, Sweden;6 Department of Clinical Sciences, Endocrinology and Diabetes, Lund University, Lund, SwedenView further author information
,
Lars Mikael Broman7 ECMO Centre Karolinska, Pediatric Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden;8 Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, SwedenORCID Iconhttps://orcid.org/0000-0003-4124-4581View further author information
ORCID Icon,
Hanan Tanash9 Department of Clinical Sciences, Respiratory Medicine, Lund University, Malmö, Sweden;10 Department of Respiratory Medicine, Skåne University Hospital, Malmö, SwedenView further author information
,
Mona Landin-Olsson5 Diabetes Research Laboratory, Biomedical Center, Lund University, Lund, Sweden;6 Department of Clinical Sciences, Endocrinology and Diabetes, Lund University, Lund, SwedenView further author information
,
Magnus Rasmussen1 Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, SwedenView further author information
&
Maria Thunander2 Department of Research and Development, Health Care Region Kronoberg, Växjö, Sweden;6 Department of Clinical Sciences, Endocrinology and Diabetes, Lund University, Lund, Sweden;11 Department of Internal Medicine, Endocrinology, Växjö Central Hospital, Växjö, SwedenView further author information
 show all
Pages 5843-5848 | Published online: 28 Jun 2022

References

  • Yang C, Chapman KR, Wong A, et al. α1-antitrypsin deficiency and the risk of COVID-19: an urgent call to action. Lancet Respir Med. 2021;9(4):337–339. doi:10.1016/S2213-2600(21)00018-7
  • Oguntuyo KY, Stevens CS, Siddiquey MN, et al. In plain sight: the role of alpha-1-antitrypsin in COVID-19 pathogenesis and therapeutics. bioRxiv. 2020. doi:10.1101/2020.08.14.248880
  • Strnad P, Mcelvaney NG, Lomas DA. Alpha1-antitrypsin deficiency. N Engl J Med. 2020;382(15):1443–1455. doi:10.1056/NEJMra1910234
  • Faria N, Inês Costa M, Gomes J, et al. Alpha-1 antitrypsin deficiency severity and the risk of COVID-19: a Portuguese cohort. Respir Med. 2021;181:106387. doi:10.1016/j.rmed.2021.106387
  • Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.e278. doi:10.1016/j.cell.2020.02.052
  • Wettstein L, Weil T, Conzelmann C, et al. Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection. Nat Commun. 2021;12(1). doi:10.1038/s41467-021-21972-0
  • Yang C, Keshavjee S, Liu M. Alpha-1 antitrypsin for COVID-19 treatment: dual role in antiviral infection and anti-inflammation. Front Pharmacol. 2020;11. doi:10.3389/fphar.2020.615398
  • Bai X, Hippensteel J, Leavitt A, et al. Hypothesis: alpha-1-antitrypsin is a promising treatment option for COVID-19. Med Hypotheses. 2021;146:110394. doi:10.1016/j.mehy.2020.110394
  • Vianello A, Guarnieri G, Braccioni F, et al. Correlation between α1-antitrypsin deficiency and SARS-CoV-2 infection: epidemiological data and pathogenetic hypotheses. J Clin Med. 2021;10(19):4493. doi:10.3390/jcm10194493
  • Shapira G, Shomron N, Gurwitz D. Ethnic differences in alpha‐1 antitrypsin deficiency allele frequencies may partially explain national differences in COVID‐19 fatality rates. FASEB J. 2020;34(11):14160–14165. doi:10.1096/fj.202002097
  • Vianello A, Braccioni F. Geographical overlap between alpha-1 antitrypsin deficiency and COVID-19 infection in Italy: casual or causal? Archivos de Bronconeumología. 2020;56(9):609–610. doi:10.1016/j.arbres.2020.05.015
  • Ferrarotti I, Ottaviani S, Balderacchi AM, et al. COVID-19 infection in severe Alpha 1-antitrypsin deficiency: looking for a rationale. Respir Med. 2021;183:106440. doi:10.1016/j.rmed.2021.106440
  • Blanco I. Estimated numbers and prevalence of PI*S and PI*Z alleles of Alpha-1-antitrypsin deficiency in European countries. Eur Respir J. 2006;27(1):77–84. doi:10.1183/09031936.06.00062305
  • Hjalmarsson K. Distribution of alpha-1-antitrypsin phenotypes in Sweden. Hum Hered. 1988;38(1):27–30. doi:10.1159/000153750
  • The Public Health Agency of Sweden. Confirmed cases of COVID-19. 2021. Available from: https://www.folkhalsomyndigheten.se/smittskydd-beredskap/utbrott/aktuella-utbrott/covid-19/statistik-och-analyser/bekraftade-fall-i-sverige/. Accessed August 24, 2021.
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8
  • Sveger T. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med. 1976;294(24):1316–1321. doi:10.1056/NEJM197606102942404
  • Mostafavi B, Piitulainen E, Tanash HA. Survival in the Swedish cohort with alpha-1-antitrypsin deficiency, up to the age of 43–45 years. Int J Chron Obstruct Pulmon Dis. 2019;14:525–530. doi:10.2147/COPD.S183205
  • Tanash HA, Ekström M, Rönmark E, et al. Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits. Eur Respir J. 2017;50(3):1700198. doi:10.1183/13993003.00198-2017
  • Sanders CL, Ponte A, Kueppers F. The effects of inflammation on alpha 1 antitrypsin levels in a national screening cohort. J Chronic Obstruct Pulmon Dis. 2018;15(1):10–16. doi:10.1080/15412555.2017.1401600
  • Schneider CV, Strnad P. SARS-CoV-2 infection in alpha1-antitrypsin deficiency. Respir Med. 2021;184:106466. doi:10.1016/j.rmed.2021.106466

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.